Dr. Gary E. Goodman
Claim this profileProvidence Portland Medical Center
Studies Parotid Gland Cancer
Studies Lung Cancer
17 reported clinical trials
40 drugs studied
About Gary E. Goodman
Education:
- Obtained an MD from the University of California, San Francisco, School of Medicine in 1986.
- Completed a Residency in Internal Medicine at Oregon Health & Science University (1986-1989).
- Undertook a Fellowship in Hematology/Oncology at Oregon Health & Science University (1989-1992).
Experience:
- Currently practices as a hematologist and oncologist at Providence Portland Medical Center.
Area of expertise
1Parotid Gland Cancer
Stage IV
Stage III
BRAF negative
2Lung Cancer
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Gary E. Goodman is currently running
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Lenalidomide +/- Daratumumab
for Multiple Myeloma
Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenance and then registered to Reg Step 2 (first randomization). Patients are randomized between Lenalidomide for 2 years and Lenalidomide + Daratumumab/rHuPH20. After 2 years of Maintenance, MRD is assessed to guide further therapy. MRD-positive patients will continue with the assigned treatment. MRD-negative patients will be further randomized (Reg Step 3) to either continue or discontinue the assigned treatment. Patients are treated for up to 7 years from Step 2 reg and followed for up to 15 years.
Recruiting2 awards Phase 317 criteria
More about Gary E. Goodman
Clinical Trial Related6 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Gary E. Goodman has experience with
- Ramucirumab
- Paclitaxel
- Irinotecan Hydrochloride
- Gemcitabine Hydrochloride
- Lenalidomide
- Daratumumab/rHuPH20
Breakdown of trials Gary E. Goodman has run
Parotid Gland Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Gary E. Goodman specialize in?
Is Gary E. Goodman currently recruiting for clinical trials?
Are there any treatments that Gary E. Goodman has studied deeply?
What is the best way to schedule an appointment with Gary E. Goodman?
What is the office address of Gary E. Goodman?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.